Founder & President
With over 25 years of leadership in nursing and clinical research, Alicia Sable-Hunt founded EHG with a mission: to integrate the patient voice into every layer of clinical research while delivering operational excellence and strategic intelligence to sponsors, CROs, and investors. From managing complex oncology trials to building nationally recognized biospecimen programs, Alicia has led with both heart and precision. Her work reflects the core of EHG’s tagline:
Patient-Empowered Research.
Operational Precision.
Strategic Intelligence.
She has served at the intersection of patient advocacy and data integrity, ensuring clinical trials are not only compliant and efficient—but also human-centered. Her ability to navigate both bedside and boardroom has made her a trusted partner to non-profit foundations, pharmaceutical sponsors, diagnostics companies, and private equity firms.
A Track Record That Delivers Across Sectors
Alicia’s early career began in bedside oncology nursing, eventually evolving into site leadership roles where she managed phase II–IV trials and launched a disease-specific clinical trials network and biorepository. In 2007, she founded EHG to meet a growing need for patient-focused, operationally sound clinical research support. Since then, her scope has expanded across therapeutic areas—from rare diseases and oncology to infectious disease, endocrinology, and sexual health. Today, she leads a team delivering end-to-end support for clinical research operations, real-world data collection, and due diligence consulting for hedge funds and private equity groups evaluating healthcare assets.
Industry Leadership & Recognition
This website uses cookies. By continuing to use this site, you accept our use of cookies.